Skip to content

Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging

Optimisation and Quantification of Contrast Enhanced Computed Tomography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02364687
Enrollment
40
Registered
2015-02-18
Start date
2013-10-31
Completion date
2023-05-31
Last updated
2023-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Brief summary

Detecting scarred heart muscle is important to diagnose and treat of a wide variety of heart conditions. Magnetic resonance imaging (MRI) can assess scarred heart muscle but it is time consuming, contraindicated for some patients and not tolerated by others. Computed tomography (CT) imaging has the potential to provide a rapid comprehensive assessment of the heart. This study will assess CT imaging of the heart muscle of patients who have previously undergone MRI of their heart. Using a state of the art CT scanner the investigators will develop a low radiation dose protocol to identify scarred heart muscle. The investigators will use and develop software techniques to analyse these images. This will enable us to develop a new way to identify and measure scarred heart muscle that will benefit patients with heart disease.

Interventions

RADIATIONComputed tomography late enhancement imaging

Sponsors

University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presence of late enhancement on magnetic resonance imaging

Exclusion criteria

* age less than 40 * inability or unwillingness to undergo CT * renal failure (serum creatinine \>200 umol/l or estimated glomerular filtration rate \<30 ml/min) * hepatic failure * allergy to iodinated contrast * pregnancy * breast feeding * inability to undergo informed consent * fast atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Myocardial late enhancementImmediateThe amount of myocardial late enhancement measured on computed tomography as compared to magnetic resonance imaging.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026